Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences.

@article{Locadia2004TreatmentOV,
  title={Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences.},
  author={Mirjam Locadia and Patrick M. M. Bossuyt and Peep F. M. Stalmeier and Mirjam A. G. Sprangers and Carlo J J van Dongen and Saskia Middeldorp and Ivan Bank and Jan van der Meer and Karly Hamul{\'y}ak and Martin H. Prins},
  journal={Thrombosis and haemostasis},
  year={2004},
  volume={92 6},
  pages={1336-41}
}
Determining the optimal duration of vitamin K antagonist (VKA) therapy for patients with venous thromboembolism (VTE) requires a weighting of the benefits and risks of treatment. The objectives of our study were to investigate patient variability in health state valuations associated with VKA therapy and treatment preferences, and to investigate the extent to which valuations and treatment preferences are associated with prior experience with these health states and other patient… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Similar Papers

Loading similar papers…